Sanquan Medical College Risk Report

📜 Innovation & R&D

Sanquan Medical College demonstrates a strong focus on research and innovation, particularly in the field of medical science. Their efforts are illustrated through various studies and publications, aiming to refine and expand knowledge in medical education and practice. Despite some setbacks, such as retractions in research, the institution remains committed to advancing scientific understanding.

• A study published on 🗓 October 28, 2023, involving perfluorooctane sulfonic acid exposure and diabetes, highlights the college's engagement in important public health research.
• On 🗓 October 23, 2023, research was conducted on ferritinophagy-mediated apoptosis, indicating a focus on investigating cellular mechanisms and pathways.
• The college experienced a retraction on 🗓 July 4, 2024, for a study on the use of amorphous selenium nanoparticles aimed at improving vascular function.
• Another notable study addressing the inhibition of EMT in CT26 cells via ferritinophagic flux was published on 🗓 June 20, 2019.